Tag Archives: Cannabis sativa

Hemp as a substitute for graphene in supercapacitors

As a member of the Cannabis plant family, hemp has an undeserved reputation due to its cousin’s (marijuana) notoriety and consciousness-altering properties. Hemp is, by contrast, the Puritan in the family, associated by the knowledgeable with virtues of thrift and hard work.

An Aug. 12, 2014 news item on Nanowerk highlights a hemp/supercapacitor presentation at the 248th meeting of the American Chemical Society (ACS),

As hemp makes a comeback in the U.S. after a decades-long ban on its cultivation, scientists are reporting that fibers from the plant can pack as much energy and power as graphene, long-touted as the model material for supercapacitors. They’re presenting their research, which a Canadian start-up company is working on scaling up, at the 248th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.

David Mitlin, Ph.D., explains that supercapacitors are energy storage devices that have huge potential to transform the way future electronics are powered. Unlike today’s rechargeable batteries, which sip up energy over several hours, supercapacitors can charge and discharge within seconds. But they normally can’t store nearly as much energy as batteries, an important property known as energy density. One approach researchers are taking to boost supercapacitors’ energy density is to design better electrodes. Mitlin’s team has figured out how to make them from certain hemp fibers — and they can hold as much energy as the current top contender: graphene.

An Aug. 12, 2014 ACS news release features David Mitlin, formerly of the University of Alberta (Canada) where this research took place,, Mitlin is now with now with Clarkson University in New York,

“Our device’s electrochemical performance is on par with or better than graphene-based devices,” Mitlin says. “The key advantage is that our electrodes are made from biowaste using a simple process, and therefore, are much cheaper than graphene.”

The race toward the ideal supercapacitor has largely focused on graphene — a strong, light material made of atom-thick layers of carbon, which when stacked, can be made into electrodes. Scientists are investigating how they can take advantage of graphene’s unique properties to build better solar cells, water filtration systems, touch-screen technology, as well as batteries and supercapacitors. The problem is it’s expensive.

Mitlin’s group decided to see if they could make graphene-like carbons from hemp bast fibers. The fibers come from the inner bark of the plant and often are discarded from Canada’s fast-growing industries that use hemp for clothing, construction materials and other products. …

His team found that if they heated the fibers for 24 hours at a little over 350 degrees Fahrenheit, and then blasted the resulting material with more intense heat, it would exfoliate into carbon nanosheets.

Mitlin’s team built their supercapacitors using the hemp-derived carbons as electrodes and an ionic liquid as the electrolyte. Fully assembled, the devices performed far better than commercial supercapacitors in both energy density and the range of temperatures over which they can work. The hemp-based devices yielded energy densities as high as 12 Watt-hours per kilogram, two to three times higher than commercial counterparts. They also operate over an impressive temperature range, from freezing to more than 200 degrees Fahrenheit.

“We’re past the proof-of-principle stage for the fully functional supercapacitor,” he says. “Now we’re gearing up for small-scale manufacturing.”

I have not been able to confirm the name for Mitlin’s startup but I think it’s called Alta Supercaps (Alta being an abbreviation for Alberta,, amongst other things, and supercaps for supercapacitors) as per the information about a new startup on the Mitlin Group webspace (scroll down to the July 2, 2013 news item) which can still be found on the University of Alberta website (as of Aug. 12, 2014).

For those who would like more technical details, there is this July 2013 article by Mark Crawford for the ASME (American Society of Mechanical Engineers); Note: A link has been removed.

Activated carbons, templated carbons, carbon nanofibers, carbon nanotubes, and graphene have all been intensively studied as materials for supercapacitor electrodes. High manufacturing costs is one issue—another is that the power characteristics of many of these carbons are limited. This is a result of high microporosity, which increases ion transport limitations.

“It is becoming well understood that the key to achieving high power in porous electrodes is to reduce the ion transport limitations” says Mitlin. “Nanomaterials based on graphene and their hybrids have emerged as a new class of promising high-rate electrode candidates—they are, however, too expensive to manufacture compared to activated carbons derived from pyrolysis of agricultural wastes, or from the coking operations.”

Biomass, which mainly contains cellulose and lignin by-products, is widely utilized as a feedstock for producing activated carbons. Mitlin decided to test hemp bast fiber’s unique cellular structure to see if it could produce graphene-like carbon nanosheets.

Hemp fiber waste was pressure-cooked (hydrothermal synthesis) at 180 °C for 24 hours. The resulting carbonized material was treated with potassium hydroxide and then heated to temperatures as high as 800 °C, resulting in the formation of uniquely structured nanosheets. Testing of this material revealed that it discharged 49 kW of power per kg of material—nearly triple what standard commercial electrodes supply, 17 kW/kg.

Mitlin and his team successfully synthesized two-dimensional, yet interconnected, carbon nanosheets with superior electrochemical storage properties comparable to those of state-of-the-art graphene-based electrodes. “We were able to achieve this by employing a biomass precursor with a unique structure—hemp bast fiber,” says Mitlin. “The resultant graphene-like nanosheets possess fundamentally different properties—such as pore size distribution, physical interconnectedness, and electrical conductivity—as compared to conventional biomass-derived activated carbons.”

This image from Wikimedia was used to illustrate the Crawford article,

Hemp bast fiber is a low-cost graphene-like nanomaterial. Image: Wikimedia Commons

Hemp bast fiber is a low-cost graphene-like nanomaterial. Image: Wikimedia Commons

It seems to me that over the last few months there have been more than the usual number of supercapacitor stories, which makes the race to create the one that will break through in the marketplace fascinating to observe.

Aphios gets a patent to deliver cannabis (marijuana) at the nanoscale

A Nov. 4, 2013 news item on Nanowerk features Aphios Corporation and its successful application for a cannibis-themed patent,

Aphios Corporation today announced that it received notification of allowance for a United States Patent entitled “Nanoencapsulated Delta-9-Tetrahydrocannabinol” for the oral delivery of cannabinoids such as Δ9-THC in biodegradable polymer nanoparticles.”

According to Dr. Trevor P. Castor, co-inventor of the technology, “The patented technology will be utilized in the manufacturing of APH-0812 for pain and cachexia in AIDS and cancer patients, and APH-1305 for Multiple Sclerosis and other CNS disorders. The nanotech formulation of Δ9-THC will also have applicability in several other chronic diseases such as obesity, smoking cessation and schizophrenia.”

There is, currently, a commercially available product (Marinol®) but there are some disadvantages that the Aphios technology bypasses (from the Nov. 4, 2013 news item on FreshNews.com),

For the novel patented formulation, pharmaceutical grade Δ9-THC and other cannabinoids from Cannabis sativa with a >99% purity are first manufactured following cGMP utilizing Aphios’ patented SFS-CXP manufacturing technology platform. Our scientists and engineers then utilize Aphios’ patented SFS-PNS polymer nanospheres technology platform to encapsulate Δ9-THC in a biodegradable polymer. Nanoencapsulation protects Δ9-THC transport to the stomach, enhances its passage across the stomach lining of the gut and protects it from first pass metabolism in the liver. Nanoencapsulation slows the release of Δ9-THC, controlling the amount of drug in the bloodstream and reducing the frequency of drug administration during the day. Alternatively, the nanoformulation will be utilized to deliver Δ9-THC and other cannabinoids from a subcutaneously implanted depot.

You can find out more about Aphios including this from the Company Overview webpage,

We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders such as Alzheimer’s Disease.

Aphios®, which means “virus-free” in Greek, was founded in 1993 as a Delaware C corporation. The company was founded by Dr. Trevor P. Castor, President and CEO, to develop enabling technology platforms around the delivery and viral safety of biologics such as human plasma and recombinant therapeutics, hence its “virus-free” name. At its founding, the Company elected to spend about 10% of its research activities on investigating natural therapeutics. This interest has evolved to the realization that in order to solve the problems of cancer and aging, we have to look to nature, marine organisms and terrestrial plants that have learned how to control cell growth and cancerous mutation, often living for hundreds to thousands of years.

There’s no question humans and other animals have benefited greatly from therapeutics derived from nature but there’s at least one case, artemisinin, where we might be better off if the therapy is delivered from its  more or less natural state, a tea brewed from the plant, rather than as a refined drug, artemisinin combination therapy (or ACT) purchased from Sanofi (aka, Sanofi-Aventis), a French, multi-national pharmaceutical company, as per the discussion in my April 12, 2013 posting.